BRIEF published on 08/19/2025 at 15:43, 6 months 14 days ago The Vanguard Group Discloses Position in NCC Group plc Takeover Code Securities Disclosure Vanguard Group Shares Acquisition NCC Group
BRIEF published on 08/19/2025 at 15:42, 6 months 14 days ago The Vanguard Group Discloses Position in Mural Oncology plc Ordinary Shares Disclosure Vanguard Group Irish Takeover Mural Oncology
BRIEF published on 08/19/2025 at 15:41, 6 months 14 days ago The Vanguard Group Discloses Position in Just Group Plc The Vanguard Group Takeover Code Securities Disclosure Stock Positions Just Group Plc
BRIEF published on 08/19/2025 at 15:41, 6 months 14 days ago The Vanguard Group Discloses Position in Unite Group plc Takeover Code Securities Disclosure Vanguard Group Investment Position Unite Group Plc
BRIEF published on 08/19/2025 at 15:40, 6 months 14 days ago The Vanguard Group Discloses Interests in Spectris plc Ordinary Shares Takeover Code Securities Disclosure Vanguard Group Spectris Plc
BRIEF published on 08/19/2025 at 15:39, 6 months 14 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Form 8.3 Takeover Code Securities Disclosure Vanguard Group American Axle
BRIEF published on 08/19/2025 at 15:38, 6 months 14 days ago The Vanguard Group, Inc. Discloses Position in Qualcomm Disclosure Takeover Code Vanguard Group Securities Holding Qualcomm
PRESS RELEASE published on 08/19/2025 at 15:38, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.92% stake in NCC Group plc as of 18 August 2025 in compliance with Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Rule 8.3 Takeover Code NCC Group Plc
PRESS RELEASE published on 08/19/2025 at 15:37, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses ownership of 4.47% stake in Mural Oncology plc. No other disclosures made. Form 8.3 submitted to Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Ownership Disclosure Mural Oncology Plc
PRESS RELEASE published on 08/19/2025 at 15:36, 6 months 14 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 5.34% interest in Just Group plc. Purchase of 10p ordinary securities at 2.11 GBP per unit disclosed Securities Disclosure Vanguard Group Purchase Just Group Plc
Published on 03/02/2026 at 17:40, 32 minutes ago Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
Published on 03/02/2026 at 16:00, 2 hours 12 minutes ago MWC 2026: Amdocs Announces Research Collaboration with Stanford Researchers to Study AI's Impact on Software Engineering Productivity
Published on 03/02/2026 at 15:22, 2 hours 50 minutes ago Silver Spruce Resources Inc. Announces Non-Brokered Private Placement for Proceeds of up to $2,000,000
Published on 03/02/2026 at 15:00, 3 hours 12 minutes ago Norsemont Targets Filing Environmental Impact Declaration in December 2026
Published on 03/02/2026 at 18:05, 7 minutes ago Huawei Cloud Summit at MWC26: Solving Industry Challenges with AI
Published on 03/02/2026 at 17:25, 47 minutes ago Huawei Releases the Fully Connected Industrial Networks Report, Aiming to Promote the Upgrade of Smart Factory Architecture
Published on 03/02/2026 at 16:35, 1 hour 37 minutes ago Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Published on 03/02/2026 at 16:25, 1 hour 47 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 03/02/2026 at 17:35, 37 minutes ago Disclosure of transactions in own shares from February 23 to February 27, 2026
Published on 03/02/2026 at 08:45, 9 hours 27 minutes ago Imerys: 2025 consolidated financial statements
Published on 02/27/2026 at 23:00, 2 days 19 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 3 days ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
